Business

Pergamum actively works with each project from a business development perspective. Pergamum welcomes interest from potential partners, licensees or buyers for its current development projects and will evaluate these opportunities as they occur.

Within Pergamum’s portfolio there are also a number of spin-out opportunities outside the main therapeutic focus area. The objective for these projects is to find co-development partners or licensees at an early stage of development.

For details regarding business development opportunities please contact Jørgen Thorball.

News

Pharmasurgics to begin Phase II Clinic...
December 03, 2009
Pharmasurgics AB – part of the Karolinska Development dermatology and wound healing company "Pergamum" – today announced that Pharmasurgics has received...
Read more >>

Dermagen Reports Successful Phase I/II...
December 02, 2009
DermaGen AB today announced that it has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a...
Read more >>

Pergamum appoints Jørgen Thorball as N...
November 30, 2009
Karolinska Development AB and Pergamum AB announced today the appointment of Jørgen Thorball as Chairman of the Board of Directors of...
Read more >>